PRESS RELEASE published on 10/02/2023 at 18:00, 2 years 7 months ago Abivax highlights obefazimod ulcerative colitis program with new data to be presented at the UEG Week 2023
PRESS RELEASE published on 09/29/2023 at 23:00, 2 years 7 months ago Abivax files registration statement for proposed initial public offering in the United States
PRESS RELEASE published on 09/29/2023 at 18:00, 2 years 7 months ago Abivax announces the release of its 2023 half-year financial report
PRESS RELEASE published on 09/21/2023 at 18:00, 2 years 7 months ago Abivax presents first-half 2023 financial results
PRESS RELEASE published on 09/07/2023 at 08:00, 2 years 7 months ago Abivax provides business and operational update
PRESS RELEASE published on 08/23/2023 at 18:00, 2 years 8 months ago Abivax appoints Patrick Malloy as Senior Vice President Investor Relations
PRESS RELEASE published on 08/21/2023 at 08:00, 2 years 8 months ago Abivax secures up to EUR 150M from two structured debt financing transactions
PRESS RELEASE published on 08/10/2023 at 18:00, 2 years 8 months ago Abivax announces plans to conduct registered public offering in the United States
PRESS RELEASE published on 08/02/2023 at 18:00, 2 years 9 months ago ABIVAX: NOTICE TO HOLDERS OF BONDS CONVERTIBLE AND/OR EXCHANGEABLE INTO NEW AND/OR EXISTING SHARES (OCEANE) WITH A NOMINAL VALUE OF EUR 24,999,975.99
PRESS RELEASE published on 07/11/2023 at 18:00, 2 years 9 months ago Abivax announces the appointment of June Lee, M.D. and Troy Ignelzi as Members of the Board of Directors
Published on 05/02/2026 at 21:00, 18 hours 48 minutes ago GECC Subsidiary Provides Update on its Lawsuit for Damages Against the Lender of the Atmosphere Project
Published on 05/02/2026 at 01:30, 1 day 14 hours ago Uraniumx Reports Strong Financial Position Ahead of Spring Drill Program
Published on 05/02/2026 at 00:50, 1 day 14 hours ago CoTec Announces Annual Stock Option, Restricted Share Unit And Deferred Share Unit Grants
Published on 05/02/2026 at 00:00, 1 day 15 hours ago Redwood AI Announces Enhanced AI Models, Increasing Evaluated Chemical Reactions Following Preliminary Results from UBC Collaboration
Published on 05/02/2026 at 00:00, 1 day 15 hours ago Onco-Innovations Expands Manufacturing Scale-Up of Its PNKP Inhibitor Technology with Dalton Pharma Services, Advancing Multi-Kilogram Non-GMP Synthesis to Support IND-Enabling Studies
Published on 05/03/2026 at 04:45, 11 hours 3 minutes ago GWM Unveils World-Class Safety & Testing Facilities: Safety Built on Data, Not Hype
Published on 05/02/2026 at 15:35, 1 day ago Ecuador's banana sector renews labor agreement, with jobs meeting global standards
Published on 05/01/2026 at 19:23, 1 day 20 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 04/30/2026 at 20:00, 2 days 19 hours ago AMA Corp PLC : FY 2025 Earnings & Q1 2026 Revenue
Published on 04/30/2026 at 19:16, 2 days 20 hours ago AXA announces the results of its Shareholders' Meeting
Published on 04/30/2026 at 19:00, 2 days 20 hours ago Capital increase through exercise of subscription rights
Published on 04/30/2026 at 18:10, 2 days 21 hours ago Minutes of the Combined General Meeting held on April 30, 2026
